首页> 外文期刊>Analytical methods >Separation of all-trans- and 13-cis-isomers of acitretin on a reversed-phase column, optimization of stability conditions and their simultaneous quantitation in human plasma by liquid chromatography-tandem mass spectrometry
【24h】

Separation of all-trans- and 13-cis-isomers of acitretin on a reversed-phase column, optimization of stability conditions and their simultaneous quantitation in human plasma by liquid chromatography-tandem mass spectrometry

机译:反相色谱柱上阿维A酸全反式和13-顺式异构体的分离,稳定性条件的优化及其在人血浆中的液相色谱-串联质谱同时定量

获取原文
           

摘要

A selective, sensitive and high throughput liquid chromatography-tandem mass spectrometry (LC-ESI-MS/MS) method has been developed and validated for the chromatographic separation and quantitation of all-trans-acitretin and 13-cis-acitretin in human plasma. Sample clean-up involved solid phase extraction of both the isomers and their deuterated analogs (all-trans-acitretin-d3 and 13-cis-acitretin-d3) used as internal standards from 300 μL human plasma. Both the analytes were chromatographically separated with a resolution factor of 2.3 on a Gemini C18 (50 × 2.0 mm, 3 μ) analytical column using 10 mM ammonium acetate and acetonitrile (60?:?40, v/v) as the mobile phase. The selectivity factor (α) of the column for the separation was 1.28, based on the capacity factors of 4.56 and 5.84 for (all-trans) and (13-cis)-isomers respectively. The parent → product ion transitions for both the isomers (m/z 325.2 → 266.0) and IS (m/z 328.0 → 266.0) were monitored on a triple quadrupole mass spectrometer, operating in the multiple reaction monitoring (MRM) and negative ion mode. The method was validated over the concentration range of 0.3–500 ng mL?1 for both the analytes. Stability studies were conducted in plasma to check the extent of photoisomerization under different conditions. Quantitative and consistent recovery (92%) was obtained in the presence of L-ascorbic acid and yellow light (589 nm) for both the analytes. The matrix effect was assessed by post-column analyte infusion and the precision value (% CV) for a relative matrix effect in six different lots of plasma samples was ≤3.9% at the LLOQ levels for both the analytes. The method was successfully applied to a pivotal bioequivalence study in 48 healthy Indian subjects after oral administration of 25 mg acitretin tablet formulation under fasting conditions. To demonstrate the reproducibility in the measurement of study data, an incurred sample reanalysis was done with 270 subject samples and the % change in concentration from the initial analysis was within ±15%...
机译:已开发出一种选择性,灵敏且高通量的液相色谱-串联质谱(LC-ESI-MS / MS)方法,并已用于人血浆中全反式阿维甲酸和13-顺式阿维甲酸的色谱分离和定量验证。样品净化涉及从300μL人血浆中用作内标的异构体及其氘代类似物(全反式阿维A-d3和13-顺阿维A-d3)的固相萃取。在Gemini C18(50×2.0 mm,3μ)分析柱上,使用10 mM乙酸铵和乙腈(60?:?40,v / v)作为流动相,以2.3的分离度对两种分析物进行色谱分离。基于分别用于(全反式)和(13-顺式)异构体的容量系数4.56和5.84,分离柱的选择性系数(α)为1.28。异构体(m / z 325.2→266.0)和IS(m / z 328.0→266.0)的母体→产物离子跃迁均在三重四极杆质谱仪上进行监测,并以多反应监测(MRM)和负离子模式运行。该方法在两种分析物的浓度范围为0.3–500 ng mL?1时均得到验证。在血浆中进行了稳定性研究,以检查在不同条件下的光异构化程度。在两种分析物均存在L-抗坏血酸和黄光(589 nm)的情况下,获得了定量且一致的回收率(> 92%)。通过柱后分析物注入评估基质效应,在两种分析物的LLOQ水平下,六个不同批次血浆样品中相对基质效应的精度值(%CV)≤3.9%。在禁食条件下口服25 mg阿维A片制剂后,该方法已成功应用于48位印度健康受试者的关键生物等效性研究。为了证明研究数据测量的可重复性,对270个受试者样品进行了样品再分析,与初始分析相比浓度变化的百分比在±15%以内...

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号